For: | Li XL, Li T, Du QC, Yang L, He KL. Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19. World J Clin Cases 2021; 9(20): 5462-5469 [PMID: 34307600 DOI: 10.12998/wjcc.v9.i20.5462] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i20/5462.htm |
Number | Citing Articles |
1 |
Poornima Vinod, Vinod Krishnappa, William Rathell Jr., Godwin Dogbey, Hiten Patel, William Herzog. Effect of Renin-Angiotensin-Aldosterone System Blockers on Adverse Outcomes in COVID-19 Patients. Cardiology 2024; : 1 doi: 10.1159/000540499
|
2 |
Zhen-Mu Jin, Ji-Chan Shi, Mo Zheng, Que-Lu Chen, Yue-Ying Zhou, Fang Cheng, Jing Cai, Xian-Gao Jiang. Increased levels of lactate dehydrogenase and hypertension are associated with severe illness of COVID-19. World Journal of Clinical Cases 2022; 10(1): 128-135 doi: 10.12998/wjcc.v10.i1.128
|